抗コクシジウム薬の世界市場レポート 2025年

抗コクシジウム薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.2％で18億1,000万米ドルに成長します。予測期間の成長は、獣医医療の増加、動物におけるコクシジウム症の有病率の上昇、合成薬剤の使用の増加、飼料添加物の需要の増加、家畜生産の増加に起因しています。予測期間における主な動向としては、新興のコクシジウム症株による需要の急増、自然で代替的な治療法へのシフト、技術革新を促す規制当局の監視強化、抗生物質不使用の鶏肉製品に対する消費者の嗜好の高まり、ドラッグデリバリー技術の進歩、予防ヘルスケア対策への注目の高まり、水産養殖およびコンパニオンアニマル分野での用途拡大などが挙げられます。

食肉タンパク質に対する需要の増加は、今後数年間の抗コクシジウム薬市場の成長を促進すると予想されます。動物の肉に自然に含まれる肉タンパク質は、身体機能に重要な役割を果たす様々な必須アミノ酸で構成されています。このような肉タンパク質に対する需要の高まりは、人口増加、可処分所得の増加、都市化、タンパク質が豊富な食品への食生活の嗜好の変化といった要因によってもたらされています。抗コクシジウム薬は、家畜の健康と生産性の維持に役立つため、近代的な畜産において極めて重要であり、農家は持続可能かつ効率的な方法で、増大する食肉タンパク質需要を満たすことができます。例えば、経済協力開発機構（OECD）と国連食糧農業機関（FAO）が2023年7月に発表した報告書によると、世界の1人当たり平均食肉需要は2020～2022年の基準期間から2032年にかけて2％増加する見込みである一方、2022年のFAO食肉価格指数は輸出供給の減少により10％上昇しました。その結果、食肉タンパク質の需要増が抗コクシジウム薬市場の拡大に拍車をかけています。

養鶏の急増は、今後数年間、抗コクシジウム薬市場の発展を促進する見通しです。養鶏は、鶏、トルコ、アヒル、ガチョウなどの家畜化された鳥類を飼育し、肉、卵、羽毛を生産します。養鶏の増加は、タンパク質に対する需要の増加、養殖手法の向上、世界貿易の拡大に起因しています。抗コクシジウム薬は一般的に、家禽をコクシジウム症から守るための先制措置として、家禽の初期および最も影響を受けやすい成長段階において、飼料または水を通して投与されます。例えば、2023年6月にUSDA Economic Research Serviceが報告したように、2022年の養鶏セクターの総売上高は769億米ドルに急増し、前年比67％増という顕著な伸びを示しました。したがって、養鶏の急増は抗コクシジウム薬市場の急成長の触媒として機能します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗コクシジウム薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の抗コクシジウム薬市場：成長率分析
• 世界の抗コクシジウム薬市場の実績：規模と成長, 2019-2024
• 世界の抗コクシジウム薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗コクシジウム薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗コクシジウム薬市場薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• イオンフォア
• 抗生物質
• スルホンアミド
• 化学誘導体
• その他の薬物クラス
• 世界の抗コクシジウム薬市場薬物作用による、実績と予測, 2019-2024, 2024-2029F, 2034F
• コクシジウム抑制
• コクシジウム駆除性
• 世界の抗コクシジウム薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 家禽
• 豚
• 魚
• 牛
• コンパニオンアニマル
• 世界の抗コクシジウム薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• 小売薬局
• その他の流通チャネル
• 世界の抗コクシジウム薬市場、イオンフォアのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モネンシン
• ラサロシド
• サリノマイシン
• 世界の抗コクシジウム薬市場抗生物質の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• タイロシン
• リンコマイシン
• バシトラシン
• 世界の抗コクシジウム薬市場、スルホンアミドの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• スルファジメトキシン
• スルファキノキサリン
• 世界の抗コクシジウム薬市場化学誘導体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジクラズリル
• クロピドール
• 世界の抗コクシジウム薬市場、その他の薬物クラスのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アンプロリウム
• ロベニジン

第7章 地域別・国別分析

• 世界の抗コクシジウム薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗コクシジウム薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗コクシジウム薬市場：競合情勢
• 抗コクシジウム薬市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Ltd Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boehringer Ingelheim GmbH
• Zoetis Inc.
• Elanco Animal Health Incorporated
• Intas Pharmaceuticals Ltd.
• Ceva Sante Animale S.A.
• Virbac S.A.
• Phibro Animal Health Corporation
• Vetoquinol SA
• Alpharma BVBA
• Kepro B.V.
• Kemin Industries Inc.
• Tianjin Ringpu Bio-Technology Co. Ltd.
• Hester Biosciences Limited
• Huvepharma AD
• Biovet S.A.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗コクシジウム薬市場2029：新たな機会を提供する国
• 抗コクシジウム薬市場2029：新たな機会を提供するセグメント
• 抗コクシジウム薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Anticoccidial drugs constitute a category of medications employed in the prevention and treatment of coccidiosis, an intestinal parasitic ailment induced by protozoa from the genus Eimeria. These medications function by impeding diverse stages of the coccidia life cycle, thereby managing the infection and averting the consequential intestinal harm and associated symptoms. Widely utilized in veterinary practice, especially in poultry, these drugs contribute to bolstering health and productivity by addressing this prevalent and economically impactful condition.

The primary categories of anticoccidial drugs encompass ionophores, antibiotics, sulphonamides, chemical derivatives, and others. Ionophores, for instance, intervene in the proliferation and propagation of coccidia parasites by modulating ion movement across cellular membranes. These drugs exhibit varied actions, serving both coccidiostatic and coccidiocidal purposes across diverse applications such as poultry, swine, fish, cattle, and companion animals. They are distributed through various channels, including veterinary hospitals, retail pharmacies, among others.

The anticoccidial drugs market research report is one of a series of new reports from The Business Research Company that provides anticoccidial drugs market statistics, including anticoccidial drugs industry global market size, regional shares, competitors with a anticoccidial drugs market share, detailed anticoccidial drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anticoccidial drugs industry. This anticoccidial drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.

The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors.

The increasing demand for meat proteins is expected to drive the growth of the anticoccidial drug market in the coming years. Meat proteins, which are naturally found in animal flesh, consist of various essential amino acids that play a crucial role in bodily functions. This rising demand for meat proteins is driven by factors such as population growth, higher disposable income, urbanization, and changing dietary preferences toward protein-rich foods. Anticoccidial drugs are critical in modern livestock farming, as they help maintain animal health and productivity, allowing farmers to meet the growing demand for meat proteins in a sustainable and efficient manner. For example, a report published in July 2023 by the Organization for Economic Co-operation and Development (OECD) and the Food and Agriculture Organization (FAO) noted that while global average per capita meat demand is expected to rise by 2% from the 2020-2022 base period to 2032, the FAO meat price index increased by 10% in 2022 due to lower export supplies. As a result, the growing demand for meat proteins is fueling the expansion of the anticoccidial drug market.

The upsurge in poultry farming is poised to drive the advancement of the anticoccidial drug market in the coming years. Poultry farming involves the rearing of domesticated avian species such as chickens, turkeys, ducks, and geese for the production of meat, eggs, and feathers. This increase in poultry farming is attributed to a growing demand for protein, enhancements in farming methodologies, and the expansion of global trade. Anticoccidial drugs are commonly administered to poultry either through feed or water as a preemptive measure to shield the birds from coccidiosis during their initial and most susceptible growth stages. For instance, as reported by the USDA Economic Research Service in June 2023, total sales in the poultry sector soared to $76.9 billion in 2022, marking a notable 67% surge from the preceding year. Hence, the surge in poultry farming acts as a catalyst for the burgeoning growth of the anticoccidial drug market.

Leading companies in the anticoccidial drugs market are focusing on developing innovative solutions, such as synthetic coccidiostats, to improve efficacy, reduce resistance development, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound used to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For example, in March 2023, Zoetis, a US-based animal health company, introduced Avi-Deccox, a reformulated synthetic coccidiostat designed to control coccidiosis in broiler chickens. This product targets the pathogens Eimeria acervulina and Eimeria tenella, which cause significant economic losses in poultry farming. Featuring decoquinate as its active ingredient, similar to its predecessor, Deccox, Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by utilizing a different mode of action, offering a more effective short-term knockdown effect.

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc, Bayer AG, Novartis AG, Eli Lilly and Company Ltd, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Sante Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc, Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anticoccidial drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The anticoccidial drugs market consist of sales of monensin, semduramicin, lasalocid, decoquinate, salinomycin, amprolium, clopidol, and sulfachloropyrazine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anticoccidial Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anticoccidial drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anticoccidial drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anticoccidial drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Ionophore; Antibiotic; Sulphonamides; Chemical Derivative; Other Drug Classes
• 2) By Drug Action: Coccidiostatic; Coccidiocidal
• 3) By Application: Poultry; Swine; Fish; Cattle; Companion Animals
• 4) By Distribution Channel: Veterinary Hospitals; Retail Pharmacy; Other Distribution Channels
• Subsegments:
• 1) By Ionophore: Monensin; Lasalocid; Salinomycin
• 2) By Antibiotic: Tylosin; Lincomycin; Bacitracin
• 3) By Sulphonamides: Sulfadimethoxine; Sulfaquinoxaline
• 4) By Chemical Derivative: Diclazuril; Clopidol
• 5) By Other Drug Classes: Amprolium; Robenidine
• Companies Mentioned: Johnson & Johnson; Merck and Co. Inc; Bayer AG; Novartis AG; Eli Lilly and Company Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Anticoccidial Drugs Market Characteristics

3. Anticoccidial Drugs Market Trends And Strategies

4. Anticoccidial Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Anticoccidial Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Anticoccidial Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Anticoccidial Drugs Market Growth Rate Analysis
• 5.4. Global Anticoccidial Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Anticoccidial Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Anticoccidial Drugs Total Addressable Market (TAM)

6. Anticoccidial Drugs Market Segmentation

• 6.1. Global Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ionophore
• Antibiotic
• Sulphonamides
• Chemical Derivative
• Other Drug Classes
• 6.2. Global Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coccidiostatic
• Coccidiocidal
• 6.3. Global Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Poultry
• Swine
• Fish
• Cattle
• Companion Animals
• 6.4. Global Anticoccidial Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Retail Pharmacy
• Other Distribution Channels
• 6.5. Global Anticoccidial Drugs Market, Sub-Segmentation Of Ionophore, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monensin
• Lasalocid
• Salinomycin
• 6.6. Global Anticoccidial Drugs Market, Sub-Segmentation Of Antibiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tylosin
• Lincomycin
• Bacitracin
• 6.7. Global Anticoccidial Drugs Market, Sub-Segmentation Of Sulphonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfadimethoxine
• Sulfaquinoxaline
• 6.8. Global Anticoccidial Drugs Market, Sub-Segmentation Of Chemical Derivative, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diclazuril
• Clopidol
• 6.9. Global Anticoccidial Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amprolium
• Robenidine

7. Anticoccidial Drugs Market Regional And Country Analysis

• 7.1. Global Anticoccidial Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Anticoccidial Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anticoccidial Drugs Market

• 8.1. Asia-Pacific Anticoccidial Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anticoccidial Drugs Market

• 9.1. China Anticoccidial Drugs Market Overview
• 9.2. China Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anticoccidial Drugs Market

• 10.1. India Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anticoccidial Drugs Market

• 11.1. Japan Anticoccidial Drugs Market Overview
• 11.2. Japan Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anticoccidial Drugs Market

• 12.1. Australia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anticoccidial Drugs Market

• 13.1. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anticoccidial Drugs Market

• 14.1. South Korea Anticoccidial Drugs Market Overview
• 14.2. South Korea Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anticoccidial Drugs Market

• 15.1. Western Europe Anticoccidial Drugs Market Overview
• 15.2. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anticoccidial Drugs Market

• 16.1. UK Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anticoccidial Drugs Market

• 17.1. Germany Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anticoccidial Drugs Market

• 18.1. France Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anticoccidial Drugs Market

• 19.1. Italy Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anticoccidial Drugs Market

• 20.1. Spain Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anticoccidial Drugs Market

• 21.1. Eastern Europe Anticoccidial Drugs Market Overview
• 21.2. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anticoccidial Drugs Market

• 22.1. Russia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anticoccidial Drugs Market

• 23.1. North America Anticoccidial Drugs Market Overview
• 23.2. North America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anticoccidial Drugs Market

• 24.1. USA Anticoccidial Drugs Market Overview
• 24.2. USA Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anticoccidial Drugs Market

• 25.1. Canada Anticoccidial Drugs Market Overview
• 25.2. Canada Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anticoccidial Drugs Market

• 26.1. South America Anticoccidial Drugs Market Overview
• 26.2. South America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anticoccidial Drugs Market

• 27.1. Brazil Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anticoccidial Drugs Market

• 28.1. Middle East Anticoccidial Drugs Market Overview
• 28.2. Middle East Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anticoccidial Drugs Market

• 29.1. Africa Anticoccidial Drugs Market Overview
• 29.2. Africa Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anticoccidial Drugs Market Competitive Landscape And Company Profiles

• 30.1. Anticoccidial Drugs Market Competitive Landscape
• 30.2. Anticoccidial Drugs Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Anticoccidial Drugs Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim GmbH
• 31.2. Zoetis Inc.
• 31.3. Elanco Animal Health Incorporated
• 31.4. Intas Pharmaceuticals Ltd.
• 31.5. Ceva Sante Animale S.A.
• 31.6. Virbac S.A.
• 31.7. Phibro Animal Health Corporation
• 31.8. Vetoquinol SA
• 31.9. Alpharma BVBA
• 31.10. Kepro B.V.
• 31.11. Kemin Industries Inc.
• 31.12. Tianjin Ringpu Bio-Technology Co. Ltd.
• 31.13. Hester Biosciences Limited
• 31.14. Huvepharma AD
• 31.15. Biovet S.A.

32. Global Anticoccidial Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anticoccidial Drugs Market

34. Recent Developments In The Anticoccidial Drugs Market

35. Anticoccidial Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Anticoccidial Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Anticoccidial Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Anticoccidial Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer